RESEARCH & THOUGHTS
Perspectives Shaping Clinical Development
Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.
In a world where complacency is the enemy of progress, Contract Research Organizations (CROs) stand at...
Read
- Research Paper
Linear Mixed-Effects Models for Central Statistical Monitoring of Multicenter Clinical Trials
- Research Paper
Linear Mixed-Effects Models for Central Statistical Monitoring of Multicenter Clinical Trials
- Research Paper
Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials
- Research Paper
Ensuring Trial Validity by Data Quality Assurance and Diversification of Monitoring Methods
- Research Paper
Impact of On-Site Initiation Visits on Patient Recruitment and Data Quality in a Randomized Trial of Adjuvant Chemotherapy for Breast Cancer
- Research Paper
Data Fraud in Clinical Trials
- Whitepaper
Examining the Current State of ICH E6 (R2) Adoption
- Whitepaper
From RBM to RBQM: The Future of Risk-Based Trial Management
- Whitepaper
Harnessing CSM to Drive Risk-Based Quality Management (RBQM)
- Whitepaper
Conclusions from Executive Roundtable on Response to ICH E6 (R2)
- Whitepaper
Implementing a Scalable Risk-Based Monitoring Strategy
- Whitepaper
Sponsor Responses to the ICH E6 Revisions
- Research Paper
Impact of On-Site Initiation Visits on Patient Recruitment and Data Quality in a Randomized Trial of Adjuvant Chemotherapy for Breast Cancer
- Research Paper
Data Fraud in Clinical Trials
- Research Paper
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes
- Research Paper
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring
- Blog
International Women’s Day: Celine Daubresse
- Blog
International Women’s Day: Jennifer Bournique
- Blog
International Women’s Day: Catherine Ditzler
- Blog
QTLs: Where Are We, And How Much Further Can We Go?
- Blog
Leveraging RBQM In Ways You Never Envisioned
- Blog
Harnessing Risk-Based Quality Management And Deep Learning To Improve Trial Knowledge And Drive Better Outcomes – Your Questions Answered
- Blog
The Importance Of Risk Assessment As A Foundation Of RBQM
- Blog
10 Reasons People Like Working At CluePoints
- Blog
RBQM And ML: Perfect Partners For More Efficient Clinical Trials
- Blog
Twin Peaks: 10 Years Of CluePoints And Risk-Based Monitoring
- Blog
The Inaugural ACDM AI & ML Conference Promises To Move The Dial
- Blog
Natural Language Processing Improves Risk Signal Documentation In Clinical Trials
